Mutation of CEP72 Gene May Predispose Patients to Hepatotoxicity
This report describes hepatotoxicity that first developed during consolidation in a patient homozygous for the CEP72 risk alleles. Bilirubin levels normalized following dose reduction of 6-mercaptopurine. The patient continues to tolerate maintenance therapy at a reduced dose of 6-mercaptopurine.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Clinical and Laboratory Observations Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Bilirubin | Brain | Cancer & Oncology | Chemotherapy | Genetics | Hematology | Laboratory Medicine | Leukemia | Neurology | Pediatrics | Peripheral Neuropathy | Toxicology